28/120
1.2 / 5 stars
All 120 Win/Lose results shown below
QURE Roast Me summary
uniQure N.V. (QURE). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinQURE / S&P 181.71% / 15.20% |
LoseQURE / S&P QURE unavailable / 15.00% |
LoseQURE / S&P QURE unavailable / 50.40% |
| 2026-Q10/3 |
LoseQURE / S&P -31.68% / -4.33% |
LoseQURE / S&P -10.44% / 11.30% |
LoseQURE / S&P QURE unavailable / 27.70% |
| 2025-Q40/3 |
LoseQURE / S&P -59.00% / 2.65% |
LoseQURE / S&P -40.64% / 9.00% |
LoseQURE / S&P QURE unavailable / 13.40% |
| 2025-Q31/3 |
WinQURE / S&P 318.72% / 8.12% |
LoseQURE / S&P -44.90% / 4.61% |
LoseQURE / S&P QURE unavailable / 13.45% |
| 2025-Q21/3 |
WinQURE / S&P 31.51% / 10.94% |
LoseQURE / S&P -48.25% / 4.83% |
LoseQURE / S&P QURE unavailable / 10.63% |
| 2025-Q11/3 |
LoseQURE / S&P -39.98% / -4.27% |
WinQURE / S&P 6.30% / 4.98% |
LoseQURE / S&P QURE unavailable / 10.57% |
| 2024-Q42/3 |
WinQURE / S&P 258.22% / 2.41% |
WinQURE / S&P 71.17% / 5.25% |
LoseQURE / S&P QURE unavailable / 6.15% |
| 2024-Q31/3 |
WinQURE / S&P 10.04% / 5.89% |
LoseQURE / S&P -74.45% / 5.89% |
LoseQURE / S&P QURE unavailable / 6.11% |
| 2024-Q20/3 |
LoseQURE / S&P -13.85% / 4.28% |
LoseQURE / S&P -75.25% / 5.38% |
LoseQURE / S&P QURE unavailable / 5.12% |
| 2024-Q10/3 |
LoseQURE / S&P -23.19% / 10.56% |
LoseQURE / S&P -82.73% / 5.71% |
LoseQURE / S&P QURE unavailable / 5.59% |
| 2023-Q40/3 |
LoseQURE / S&P 0.89% / 11.69% |
LoseQURE / S&P -85.12% / 6.81% |
LoseQURE / S&P QURE unavailable / 7.78% |
| 2023-Q31/3 |
LoseQURE / S&P -41.45% / -3.27% |
WinQURE / S&P 82.16% / 7.52% |
LoseQURE / S&P QURE unavailable / -5.03% |
| 2023-Q21/3 |
LoseQURE / S&P -43.10% / 8.74% |
WinQURE / S&P 80.64% / 9.50% |
LoseQURE / S&P QURE unavailable / -8.57% |
| 2023-Q10/3 |
LoseQURE / S&P -11.16% / 7.50% |
LoseQURE / S&P -79.06% / 10.77% |
LoseQURE / S&P -148.48% / -15.69% |
| 2022-Q41/3 |
WinQURE / S&P 20.84% / 7.56% |
LoseQURE / S&P -79.68% / 11.88% |
LoseQURE / S&P -138.49% / -17.99% |
| 2022-Q31/3 |
WinQURE / S&P 0.64% / -4.88% |
LoseQURE / S&P -87.72% / 13.47% |
LoseQURE / S&P -139.56% / -1.41% |
| 2022-Q21/3 |
WinQURE / S&P 3.15% / -16.10% |
LoseQURE / S&P -87.61% / 13.71% |
LoseQURE / S&P -138.56% / 11.04% |
| 2022-Q11/3 |
LoseQURE / S&P -12.87% / -4.60% |
WinQURE / S&P 1287.44% / 15.97% |
LoseQURE / S&P QURE unavailable / 42.23% |
| 2021-Q41/3 |
LoseQURE / S&P -35.21% / 11.03% |
WinQURE / S&P 1296.82% / 15.00% |
LoseQURE / S&P QURE unavailable / 96.40% |
| 2021-Q32/3 |
WinQURE / S&P 3.93% / 0.58% |
WinQURE / S&P 8166.93% / 10.77% |
LoseQURE / S&P QURE unavailable / 69.42% |
| 2021-Q21/3 |
LoseQURE / S&P -8.58% / 8.55% |
WinQURE / S&P 9319.91% / 6.58% |
LoseQURE / S&P QURE unavailable / 51.81% |
| 2021-Q11/3 |
LoseQURE / S&P -6.75% / 6.17% |
WinQURE / S&P 505.92% / -1.06% |
LoseQURE / S&P QURE unavailable / 7.39% |
| 2020-Q41/3 |
LoseQURE / S&P -1.90% / 12.15% |
WinQURE / S&P 415.23% / -3.72% |
LoseQURE / S&P QURE unavailable / -33.42% |
| 2020-Q30/3 |
LoseQURE / S&P -18.26% / 8.93% |
LoseQURE / S&P -3.37% / -2.04% |
LoseQURE / S&P QURE unavailable / -27.10% |
| 2020-Q20/3 |
LoseQURE / S&P -5.04% / 20.54% |
LoseQURE / S&P -36.53% / -0.46% |
LoseQURE / S&P QURE unavailable / -27.11% |
| 2020-Q10/3 |
LoseQURE / S&P -33.78% / -19.60% |
LoseQURE / S&P -30.12% / 3.47% |
LoseQURE / S&P QURE unavailable / -14.75% |
| 2019-Q41/3 |
WinQURE / S&P 82.06% / 9.07% |
LoseQURE / S&P -35.48% / 5.36% |
LoseQURE / S&P QURE unavailable / 2.99% |
| 2019-Q30/3 |
LoseQURE / S&P -49.64% / 1.70% |
LoseQURE / S&P -48.91% / 5.02% |
LoseQURE / S&P QURE unavailable / 0.21% |
| 2019-Q21/3 |
WinQURE / S&P 31.01% / 4.30% |
LoseQURE / S&P -26.43% / 6.64% |
LoseQURE / S&P QURE unavailable / 8.65% |
| 2019-Q11/3 |
WinQURE / S&P 106.97% / 13.65% |
LoseQURE / S&P -32.58% / 8.12% |
LoseQURE / S&P QURE unavailable / 14.29% |
| 2018-Q40/3 |
LoseQURE / S&P -20.80% / -13.52% |
LoseQURE / S&P -13.91% / 9.05% |
LoseQURE / S&P QURE unavailable / 18.23% |
| 2018-Q30/3 |
LoseQURE / S&P -3.73% / 7.71% |
LoseQURE / S&P -37.62% / 10.21% |
LoseQURE / S&P QURE unavailable / 19.06% |
| 2018-Q21/3 |
WinQURE / S&P 60.85% / 3.43% |
LoseQURE / S&P -53.80% / 9.03% |
LoseQURE / S&P QURE unavailable / 14.46% |
| 2018-Q11/3 |
WinQURE / S&P 19.96% / -0.76% |
LoseQURE / S&P -45.02% / 7.68% |
LoseQURE / S&P QURE unavailable / 12.46% |
| 2017-Q41/3 |
WinQURE / S&P 104.06% / 6.64% |
LoseQURE / S&P -47.78% / 7.03% |
LoseQURE / S&P QURE unavailable / 13.82% |
| 2017-Q31/3 |
WinQURE / S&P 55.09% / 4.48% |
LoseQURE / S&P QURE unavailable / 5.68% |
LoseQURE / S&P QURE unavailable / 17.57% |
| 2017-Q21/3 |
WinQURE / S&P 7.09% / 3.09% |
LoseQURE / S&P QURE unavailable / 4.83% |
LoseQURE / S&P QURE unavailable / 17.74% |
| 2017-Q10/3 |
LoseQURE / S&P 3.21% / 6.07% |
LoseQURE / S&P QURE unavailable / 3.67% |
LoseQURE / S&P QURE unavailable / 13.32% |
| 2016-Q41/3 |
LoseQURE / S&P -26.80% / 3.82% |
WinQURE / S&P 137.27% / 2.09% |
LoseQURE / S&P QURE unavailable / 7.05% |
| 2016-Q30/3 |
LoseQURE / S&P 3.80% / 3.85% |
LoseQURE / S&P QURE unavailable / 0.20% |
LoseQURE / S&P QURE unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | QURE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 198.46% | 20.78% |
| Annualized return | 198.46% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | QURE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 65.39% | 83.14% |
| Annualized return | 10.59% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | QURE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 532.98% | 319.30% |
| Annualized return | 20.26% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |